AbbVie
Utility Patent Applications
Last updated:
List of all AbbVie patents 191 in total
| Status | Patent |
|---|---|
Application | Utility: Bromodomain Inhibitors Filling date: 12 Sep 2025 Issue date: 13 Feb 2020 |
Application | Utility: PROLINE AMIDE COMPOUNDS AND THEIR AZETIDINE ANALOGUES CARRYING A SPECIFICALLY SUBSTITUTED BENZYL RADICAL Filling date: 12 Sep 2025 Issue date: 6 Feb 2020 |
Application | Utility: Elagolix Sodium Compositions and Processes Filling date: 12 Sep 2025 Issue date: 23 Jan 2020 |
Application | Utility: ENZYMATIC PROCESS FOR THE PREPARATION OF (1S,2R)-2-(DIFLUOROMETHYL)-1-(PROPOXYCARBONYL)CYCLOPROPANECARBOXYLIC ACID Filling date: 12 Sep 2025 Issue date: 23 Jan 2020 |
Application | Utility: Macrocyclic MCL-1 Inhibitors and Methods of Use Filling date: 12 Sep 2025 Issue date: 9 Jan 2020 |
Application | Utility: ANTI-CD98 ANTIBODIES AND ANTIBODY DRUG CONJUGATES Filling date: 12 Sep 2025 Issue date: 2 Jan 2020 |
Application | Utility: ANTI-B7-H3 ANTIBODIES AND ANTIBODY DRUG CONJUGATES Filling date: 12 Sep 2025 Issue date: 2 Jan 2020 |
Application | Utility: IL-1 Binding Proteins Filling date: 12 Sep 2025 Issue date: 26 Dec 2019 |
Application | Utility: TETRACYCLIC BROMODOMAIN INHIBITORS Filling date: 12 Sep 2025 Issue date: 26 Dec 2019 |
Application | Utility: High Throughput Methods for Screening Chemical Reactions Using Reagent-Coated Bulking Agents Filling date: 12 Sep 2025 Issue date: 19 Dec 2019 |
Application | Utility: Bromodomain Inhibitors Filling date: 12 Sep 2025 Issue date: 19 Dec 2019 |
Application | Utility: INJECTION DEVICE WITH END OF DOSE INDICATOR Filling date: 12 Sep 2025 Issue date: 12 Dec 2019 |
Application | Utility: Carbidopa Prodrug Filling date: 12 Sep 2025 Issue date: 12 Dec 2019 |
Application | Utility: SUBSTITUTED ISOXAZOLOPYRIDAZINONES AND ISOTHIAZOLOPYRIDAZINONES AND METHODS OF USE Filling date: 12 Sep 2025 Issue date: 5 Dec 2019 |
Application | Utility: ANTI-CD40 ANTIBODIES AND USES THEREOF Filling date: 12 Sep 2025 Issue date: 28 Nov 2019 |
Application | Utility: Compositions and Methods for Treating HCV Infection Filling date: 12 Sep 2025 Issue date: 28 Nov 2019 |
Application | Utility: ANTI-EGFR ANTIBODY DRUG CONJUGATES Filling date: 12 Sep 2025 Issue date: 14 Nov 2019 |
Application | Utility: Bromodomain Inhibitors Filling date: 12 Sep 2025 Issue date: 14 Nov 2019 |
Application | Utility: Methods for Treating HCV Filling date: 12 Sep 2025 Issue date: 7 Nov 2019 |
Application | Utility: SELECTIVE BCL-2 INHIBITORS IN COMBINATION WITH AN ANTI-PD-1 OR AN ANTI-PD-L1 ANTIBODY FOR THE TREATMENT OF CANCERS Filling date: 12 Sep 2025 Issue date: 7 Nov 2019 |
Application | Utility: PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2- -TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF Filling date: 12 Sep 2025 Issue date: 24 Oct 2019 |
Application | Utility: PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-A]PYRROLO[2,3-E]-PYRAZIN-8-YL)-N-(2,2,2- -TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF Filling date: 12 Sep 2025 Issue date: 17 Oct 2019 |
Application | Utility: ANTI-cMet ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USE Filling date: 12 Sep 2025 Issue date: 17 Oct 2019 |
Application | Utility: APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES Filling date: 12 Sep 2025 Issue date: 17 Oct 2019 |
Application | Utility: Therapeutic DLL4 Binding Proteins Filling date: 12 Sep 2025 Issue date: 17 Oct 2019 |
Application | Utility: HIGH PURITY ORITAVANCIN AND METHOD OF PRODUCING SAME Filling date: 12 Sep 2025 Issue date: 26 Sep 2019 |
Application | Utility: Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy Filling date: 12 Sep 2025 Issue date: 26 Sep 2019 |
Application | Utility: Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy Filling date: 12 Sep 2025 Issue date: 26 Sep 2019 |
Application | Utility: COMPOSITION AND METHOD FOR THE DIAGNOSIS AND TREATMENT OF IRON-RELATED DISORDERS Filling date: 12 Sep 2025 Issue date: 26 Sep 2019 |
Application | Utility: MEDICINE CONTAINER, METHOD OF ASSEMBLING THE CONTAINER, AND METHOD OF DISPENSING THE MEDICINE FROM THE CONTAINER Filling date: 12 Sep 2025 Issue date: 26 Sep 2019 |
Application | Utility: PRIMARY CARBOXAMIDES AS BTK INHIBITORS Filling date: 12 Sep 2025 Issue date: 19 Sep 2019 |
Application | Utility: INHIBITORS OF TYROSINE KINASE 2 MEDIATED SIGNALING Filling date: 12 Sep 2025 Issue date: 12 Sep 2019 |
Application | Utility: SOLID DISPERSIONS CONTAINING AN APOPTOSIS-INDUCING AGENT Filling date: 12 Sep 2025 Issue date: 12 Sep 2019 |
Application | Utility: COMPOSITION AND METHOD FOR THE DIAGNOSIS AND TREATMENT OF DISEASES ASSOCIATED WITH NEURITE DEGENERATION Filling date: 12 Sep 2025 Issue date: 12 Sep 2019 |
Application | Utility: GLUCOCORTICOID RECEPTOR AGONIST AND IMMUNOCONJUGATES THEREOF Filling date: 12 Sep 2025 Issue date: 29 Aug 2019 |
Application | Utility: ANTIBODY DRUG CONJUGATE (ADC) PURIFICATION Filling date: 12 Sep 2025 Issue date: 29 Aug 2019 |
Application | Utility: METHODS FOR TREATING RELAPSING FORMS OF MULTIPLE SCLEROSIS Filling date: 12 Sep 2025 Issue date: 15 Aug 2019 |
Application | Utility: SEALING ARRANGEMENT FOR SYRINGE Filling date: 12 Sep 2025 Issue date: 8 Aug 2019 |
Application | Utility: WEARABLE AUTOMATIC INJECTION SYSTEM AND APPARATUS Filling date: 12 Sep 2025 Issue date: 1 Aug 2019 |
Application | Utility: METHODS OF TREATING CANCER Filling date: 12 Sep 2025 Issue date: 1 Aug 2019 |
Application | Utility: NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST THE NOGO-66 RECEPTOR (NgR) AND USES THEREOF Filling date: 12 Sep 2025 Issue date: 1 Aug 2019 |
Showing 150 to 191 of 191 patents.